HFS
TRAW icon

Hantz Financial Services’s Traws Pharma TRAW Stock Holding History

Hantz Financial Services’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2
Closed – – 1193
2023
Q1 		$0 Hold
2
– – ﹤0.01% 1218
2022
Q4 		$0 Hold
2
– – ﹤0.01% 1174
2022
Q3 		$0 Hold
2
– – ﹤0.01% 1152
2022
Q2 		$0 Hold
2
– – ﹤0.01% 1127
2022
Q1 		$0 Buy
+2
New +$93 ﹤0.01% 1132

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hantz Financial Services's TRAW Position: Q2 2023 in Review

Hantz Financial Services sold out of Traws Pharma (TRAW) in Q2 2023, closing a stake of 2 shares.

Hantz Financial Services first reported a position in TRAW in Q1 2022 and held it in 5 quarters. The position peaked at $0 in Q1 2023. 23 funds tracked by Wall St. Rank hold TRAW as of Q2 2023.

  • Hantz Financial Services reported no remaining Traws Pharma position as of Q2 2023 after selling out during the quarter.
  • Hantz Financial Services sold 2 Traws Pharma shares in Q2 2023.
  • Hantz Financial Services first reported a position in Traws Pharma in Q1 2022 and held it in 5 quarters.
  • Hantz Financial Services's Traws Pharma position peaked at $0 in Q1 2023.
  • 23 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2023.

Based on Hantz Financial Services's 13F filing for Q2 2023, filed 14 Aug 2023.